Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Ikena Oncology
Hutchmed
Eli Lilly and Company
Deciphera Pharmaceuticals, LLC
Five Prime Therapeutics, Inc.
Weill Medical College of Cornell University
Polaris Group
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Emory University
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
Envita Medical Center, Inc.
Thallion Pharmaceuticals